Forbes -
17 Jan 2014 22:19
Anyone following the stock of Intercept Pharmaceuticals (NASDAQ:ICPT) closely cannot help but get dizzy. After racing from $72 to $497 last week, the stock corrected sharply this week--trading below $250 early in the week, before recovering nicely to above $300 in the last two days.
Share this Article